IFPMA Notes for Guidance
Downloads
- Note for Guidance on social media and digital channels
- Note for Guidance on AI ethics principles
- Note for Guidance on virtual and hybrid international medical congresses
- Note for Guidance on data ethics principles
- Joint Note for Guidance on telemedicine
- Note for Guidance on ethical third party intermediary relationships
- Note for Guidance on fees for services
- Note for Guidance on interactions with patients
- Note for Guidance on sponsorship of events and meetings
- Note for Guidance on medical education
Share
Topics
The Ethos of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is centered on trust to “act with integrity and honesty to improve patient care and build trust with those we serve and to respect the independence of healthcare providers, patients, and other stakeholders.”
The purpose of the various IFPMA “Notes for Guidance” is to provide additional interpretation and further guidance in relation to the relevant provisions of the Code of Practice. Notes for Guidance are non-binding and must be read with the spirit of the Code in mind and always in accordance with applicable laws and regulations and other applicable industry codes.
IFPMA member companies and member associations and anyone acting on their behalf are encouraged to consider the guidance given in Notes for Guidance when implementing the IFPMA Code of Practice in their daily practice.
The intention of Notes for Guidance is for the cooperation between companies, HCPs, and other stakeholders to always be based on high ethical standards and to clearly aim to benefit patients.
Related news and resources
Joint Note for Guidance on social media and digital channels
In a new Note for Guidance, IFPMA and EFPIA provide non-binding advice for their members when considering their activities on social media and digital channels. The document seeks to support and guide pharmaceutical companies and associations and anyone acting on their behalf in always basing their cooperation with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs), Patient...
Read more
IFPMA Artificial Intelligence Principles
Artificial Intelligence (AI) has the potential to bring about positive transformations in science and society, including in healthcare. As a powerful enabler of progress and innovation, AI can increase individual well-being and contribute to the common good. However, while offering tremendous opportunities, relatively new AI technology could also raise concerns relating to potential misuse and inadequate accountability, as well as systemic risks inherent to algorithmic bias and discrimination.
Read more
Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles
As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient.
Read more